Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Goodwin

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
BMJ (Clinical Research Ed.)|August 24, 2002
New trial should clarify lithium use in bipolar disorderJohn Geddes, Guy Goodwin, Jennifer Rendell, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 14, 2002
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depressionHeinz Grunze, Siegfried Kasper, Guy Goodwin, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 13, 2003
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of ManiaHeinz Grunze, Siegfried Kasper, Guy Goodwin, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 23, 2008
Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statementHans-Jürgen Möller, David S Baldwin, Guy Goodwin, et al.
Pilot and Feasibility Studies|June 19, 2020
The IBER study: study protocol for a feasibility randomised controlled trial of Imagery Based Emotion Regulation for the treatment of anxiety in bipolar disorderCraig Steel, Kim Wright, Guy Goodwin, et al.
Intestinal Research|June 1, 2019
Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysisAlissa Walsh, Lawrence Matini, Christopher Hinds, et al.
The Lancet. Psychiatry|June 25, 2019
Tapering of SSRI treatment to mitigate withdrawal symptomsSudhakar Selvaraj, Sameer Jauhar, David S Baldwin, et al.
Journal of Crohn'S & Colitis|November 17, 2018
Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective AnalysisAlissa Walsh, Andrey Kormilitzin, Christopher Hinds, et al.
International Journal of Bipolar Disorders|December 16, 2014
European Network of Bipolar Research Expert Centre (ENBREC): a network to foster research and promote innovative careChantal Henry, Ole A Andreassen, Angelo Barbato, et al.
Journal of Psychopharmacology (Oxford, England)|August 14, 2015
Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scaleAngel L Montejo, J F W Deakin, Raphael Gaillard, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
BMJ (Clinical Research Ed.)|August 24, 2002
New trial should clarify lithium use in bipolar disorderJohn Geddes, Guy Goodwin, Jennifer Rendell, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|December 14, 2002
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depressionHeinz Grunze, Siegfried Kasper, Guy Goodwin, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 13, 2003
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of ManiaHeinz Grunze, Siegfried Kasper, Guy Goodwin, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 23, 2008
Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statementHans-Jürgen Möller, David S Baldwin, Guy Goodwin, et al.
Pilot and Feasibility Studies|June 19, 2020
The IBER study: study protocol for a feasibility randomised controlled trial of Imagery Based Emotion Regulation for the treatment of anxiety in bipolar disorderCraig Steel, Kim Wright, Guy Goodwin, et al.
Intestinal Research|June 1, 2019
Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysisAlissa Walsh, Lawrence Matini, Christopher Hinds, et al.
The Lancet. Psychiatry|June 25, 2019
Tapering of SSRI treatment to mitigate withdrawal symptomsSudhakar Selvaraj, Sameer Jauhar, David S Baldwin, et al.
Journal of Crohn'S & Colitis|November 17, 2018
Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective AnalysisAlissa Walsh, Andrey Kormilitzin, Christopher Hinds, et al.
International Journal of Bipolar Disorders|December 16, 2014
European Network of Bipolar Research Expert Centre (ENBREC): a network to foster research and promote innovative careChantal Henry, Ole A Andreassen, Angelo Barbato, et al.
Journal of Psychopharmacology (Oxford, England)|August 14, 2015
Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scaleAngel L Montejo, J F W Deakin, Raphael Gaillard, et al.
Pageof 4